Teva (TEVA) Enters a New $700 Million Acquisition Deal

Teva (TEVA) Enters a New $700 Million Acquisition Deal

Summary

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the Stocks that Billionaire Druckenmiller and Jim Cramer like. On April 29, 2026, Teva Pharmaceutic...

Original reporting

Open original source

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage